Myriam M Chaumeil

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma
    Myriam M Chaumeil
    Department of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th Street Box 2532, San Francisco, CA 94158, USA
    Neuroimage 59:193-201. 2012
  2. pmc Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma
    Humsa S Venkatesh
    University of California, San Francisco, San Francisco, CA 94158, USA
    Neuro Oncol 14:315-25. 2012
  3. pmc Non-invasive in vivo assessment of IDH1 mutational status in glioma
    Myriam M Chaumeil
    Department of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th Street, San Francisco, California 94158, USA
    Nat Commun 4:2429. 2013
  4. pmc Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla
    Myriam M Chaumeil
    Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA
    Neuro Oncol 14:1050-61. 2012
  5. pmc Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy
    Christopher S Ward
    Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, California 94158, USA
    Cancer Res 70:1296-305. 2010
  6. pmc Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance
    Arman Jahangiri
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94158, USA
    Clin Cancer Res 19:1773-83. 2013

Collaborators

Detail Information

Publications6

  1. pmc Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma
    Myriam M Chaumeil
    Department of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th Street Box 2532, San Francisco, CA 94158, USA
    Neuroimage 59:193-201. 2012
    ..It highlights the potential of HP lactate-to-pyruvate ratio as an early biomarker of response, thereby supporting further investigation of this non-invasive imaging approach for eventual clinical application...
  2. pmc Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma
    Humsa S Venkatesh
    University of California, San Francisco, San Francisco, CA 94158, USA
    Neuro Oncol 14:315-25. 2012
    ..This study highlights the potential of PC and hyperpolarized lactate as noninvasive MR biomarkers of response to targeted inhibitors in GBM...
  3. pmc Non-invasive in vivo assessment of IDH1 mutational status in glioma
    Myriam M Chaumeil
    Department of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th Street, San Francisco, California 94158, USA
    Nat Commun 4:2429. 2013
    ..In contrast, in cells that express mutant IDH1, hyperpolarized [1-(13)C] 2-hydroxyglutarate is also observed, both in cell lysates and in vivo in orthotopic tumours. ..
  4. pmc Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla
    Myriam M Chaumeil
    Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA
    Neuro Oncol 14:1050-61. 2012
    ..In summary, our results indicate that hMSCs and fNSCs exhibit similar properties regarding tumor tropism and intratumoral dissemination, highlighting the potential of these 2 SC sources as adequate candidates for SC-based therapies...
  5. pmc Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy
    Christopher S Ward
    Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, California 94158, USA
    Cancer Res 70:1296-305. 2010
    ....
  6. pmc Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance
    Arman Jahangiri
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94158, USA
    Clin Cancer Res 19:1773-83. 2013
    ..To identify mediators of glioblastoma antiangiogenic therapy resistance and target these mediators in xenografts...